Position in A
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,281,809
+$190,109 QoQ
Shares Held
9,650
+0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#461
of 1,112 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $2,993,663 across 4 Diagnostics & Research names. A ranks #1 (42.8% of the industry book) .
All Filings in A
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,281,809 | 9,650 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,091,700 | 9,578 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,313,755 | 9,655 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,222,533 | 9,525 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,110,002 | 9,406 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,151,083 | 9,840 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,344,206 | 10,006 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,450,352 | 9,768 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,316,911 | 10,159 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,438,948 | 9,889 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,226,800 | 8,824 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $960,757 | 8,592 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,029,219 | 8,559 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,186,127 | 8,574 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||